These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16883216)

  • 1. [Assessment of clinical course, prognosis and effectiveness of drug and nondrug treatment of patients with ischemic heart disease and occlusive coronary artery atherosclerosis (data of 5-year prospective follow-up)].
    Evstifeeva SE; Lupanov VP; Samko AN; Naumov VG
    Kardiologiia; 2006; 46(6):4-9. PubMed ID: 16883216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left main coronary stenting in a non surgical octogenarian population: a possible approach.
    Dahdouh Z; Roule V; Sabatier R; Lognoné T; Manrique A; Bignon M; Malcor G; Massetti M; Grollier G
    Cardiovasc Revasc Med; 2012; 13(2):119-24. PubMed ID: 22406303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
    Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes N; Gersh BJ; Soares PR; Ribeiro EE; Pereira AC; Favarato D; Rocha AS; Hueb AC; Ramires JA
    Circulation; 2010 Sep; 122(10):949-57. PubMed ID: 20733102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era.
    Chang K; Koh YS; Jeong SH; Lee JM; Her SH; Park HJ; Kim PJ; Kim YH; Chung WS; Yim HW; Park SJ; Seung KB
    Heart; 2012 May; 98(10):799-805. PubMed ID: 22422589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of antiischemic efficacy of balloon angioplasty, coronary bypass surgery and conservative therapy after myocardial infarction in patients with single coronary artery disease. Three year prospective study].
    Tepliakov AT; Garganeeva AA; Aptekar' VD; Rybal'chenko EV; Stepacheva TA
    Kardiologiia; 2003; 43(7):16-20. PubMed ID: 12891295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Rasoul S; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Marcel Gosselink AT; Zijlstra F; Suryapranata H; van 't Hof AW;
    Coron Artery Dis; 2009 Sep; 20(6):415-21. PubMed ID: 19641460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
    Raja SG; Benedetto U; Ilsley CD; Amrani M;
    Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
    Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
    JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function.
    Lee MS; Yang T; Biondi-Zoccai G; Sillano D; Cerrato E; Tarantini G; Xhaxho J; Aragon J; Sheiban I
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):945-51. PubMed ID: 20824773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonrandomized data on drug-eluting stents compared with coronary bypass surgery caution with interpretation.
    Head SJ; Bogers AJ; Kappetein AP
    J Am Coll Cardiol; 2011 Jun; 57(24):2457-8; author reply 2458-9. PubMed ID: 21658570
    [No Abstract]   [Full Text] [Related]  

  • 15. MY APPROACH to managing stable ischemic heart disease.
    Boden WE
    Trends Cardiovasc Med; 2015 Nov; 25(8):753-4. PubMed ID: 26410543
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study.
    Vieira RD; Pereira AC; Lima EG; Garzillo CL; Rezende PC; Favarato D; Hueb AC; Gersh BJ; Ramires JA; Hueb W
    Coron Artery Dis; 2012 Mar; 23(2):79-84. PubMed ID: 22157410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Leon MB; Kandzari DE; Eisenstein EL; Anstrom KJ; Mauri L; Cutlip DE; Nikolsky E; O'Shaughnessy C; Overlie PA; Kirtane AJ; McLaurin BT; Solomon SL; Douglas JS; Popma JJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1208-18. PubMed ID: 20129547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiogram.
    Delcour KS; Khaja A; Chockalingam A; Kuppuswamy S; Dresser T
    Angiology; 2009; 60(3):318-21. PubMed ID: 18796451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate and late results of coronary angioplasty in patients with severe left ventricular dysfunction.
    Marsico F; Morenghi E; Parenti DZ; Milone F; Maiello L; Carcagnì A; Scatturin M; Presbitero P
    Ital Heart J; 2003 Dec; 4(12):838-42. PubMed ID: 14976847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting.
    Marso SP; Ellis SG; Gurm HS; Lytle BW; Topol EJ
    Am Heart J; 2000 Jun; 139(6):939-44. PubMed ID: 10827372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.